HDAC9 and familial pancreatic carcinoma: To verify the assumed inhibitory effect of 4-PB on the HDAC activity in pancreatic cancer cells, we determined the HDAC activity in T3M-4 and BxPc3 cells treated with the drug and compared the results with an untreated control.